Journal
JOURNAL OF CELL COMMUNICATION AND SIGNALING
Volume 9, Issue 2, Pages 189-200Publisher
SPRINGER
DOI: 10.1007/s12079-015-0288-4
Keywords
Insulin like growth factor; Insulin like growth factor binding protein-6; Migration; Proliferation; Survival; Structure
Categories
Funding
- National Health and Medical Research Council of Australia
- Australian Research Council
- Cancer Council Victoria
- Alfred Research Trust
- Austin Hospital Medical Research Foundation
- Melbourne Research Grants Scheme
Ask authors/readers for more resources
IGFBP-6 is an O-linked glycoprotein that preferentially binds IGF-II over IGF-I. It is a relatively selective inhibitor of IGF-II actions including proliferation, survival and differentiation of a wide range of cells. IGFBP-6 has recently been shown to have a number of IGF-independent actions, including promotion of apoptosis in some cells and inhibition of angiogenesis. IGFBP-6 also induces migration of tumour cells including rhabdomyosarcomas by an IGF-independent mechanism. This chemotactic effect is mediated by MAP kinases. IGFBP-6 binds to prohibitin-2 on the cell surface and the latter is required for IGFBP-6-induced migration by a mechanism that is independent of MAP kinases. IGFBP-6 may enter the nucleus and modulate cell survival and differentiation. IGFBP-6 expression is decreased in a number of cancer cells and it has been postulated to act as a tumour suppressor. IGFBP-6 expression is increased in a smaller number of cancers, which may reflect a compensatory mechanism to control IGF-II actions or IGF-independent actions. The relative balance of IGF-dependent and IGF-independent actions of IGFBP-6 in vivo together with the related question regarding the roles of IGFBP-6 binding to IGF and non-IGF ligands are keys to understanding the physiological role of this protein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available